Plain-English translation of NCT06429475 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท
Phase 3 โ Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing (a combination anti-inflammatory asthma medication) to see if children and teenagers can use it flexibly โ taking it only when they need it โ rather than following the traditional approach of taking a daily maintenance dose. The study will compare this flexible approach with standard asthma care to find out which way works better and is more practical for families in South Africa.
Asthma is very common in South African children, but many still have severe symptoms despite available medications. This trial exists to find a simpler, more affordable way to deliver asthma treatment that families can actually follow and that reduces the burden of daily medication schedules.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If you join this study, you will receive either the test medication to use as needed (with or without a daily dose) or standard asthma care. You'll attend regular visits where doctors will check how well your asthma is controlled using breathing tests and by asking about your symptoms. The study will last about 12 months, with follow-up visits and some check-ins by phone to see how you're doing.
AI-generated summary from trial data ยท Jun 5, 2026 ยท Not medical advice
South Africa